Found 23 matching trials
An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients
PHASE1Given the role of IL-17 in the development of entheseal-driven pathology, a...
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers
PHASE1This is a randomized, double-blinded, controlled Phase I study of new proce...
Status
Active Not Recruiting
Location
Shanghai Jiaotong University School of Medicine
A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
PHASE4This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Palmoplantar Psoriasis
PHASE3Purpose of the study was to demonstrate the efficacy of secukinumab versus ...
Location
Novartis Investigative Site
Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX)
PHASE2This study will assess at Week 16 the efficacy and safety of AIN457 at diff...
Location
Novartis Investigative Site
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis
PHASE3The study will assess the safety and efficacy of intravenous (10mg/kg) and ...
Location
Novartis Investigative Site
Extension in AS: Sustainability of Benefits, Safety and Tolerability
PHASE3This 3-year extension study aims at making available the treatment with sec...
Location
Novartis Investigative Site
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
PHASE3The purpose of this extension study is to assess the safety and tolerabilit...
Status
Active Not Recruiting
Location
Arizona Arthritis and Rheumatology Associates PLLC
Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
PHASE3This study was designed as a 3-year extension to the phase III core study C...
Location
Novartis Investigative Site
Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement
PHASE3The purpose of this study is to demonstrate the efficacy and safety of secu...
Location
Novartis Investigative Site